Related Experiment Video
Updated: May 5, 2026

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Domain within the C protein of human parainfluenza virus type 3 that regulates interferon signaling
Hongxia Mao1, Santanu Chattopadhyay, Amiya K Banerjee
1Virology Section, Department of Molecular Genetics, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Abstract:
Human parainfluenza virus type 3 (HPIV3), one of the paramyxoviruses, uses its accessory C protein as an antagonist against interferon (IFN)-mediated host innate immunity. We have previously shown that the C protein significantly decreased the IFN-induced phosphorylation of signal transducer and activator of transcription (Stat) 1 and the formation of gamma IFN activation factor (GAF) complex, thus abrogating the antiviral activity of the IFNs against vesicular stomatitis virus (VSV) replication. Here, by mutational analyses we demonstrated that the N-terminal truncation of the C protein (CNdelta25 and CNdelta50) substantially (approximately 50%) recovers the IFN-induced responses, suggesting the critical role of the N-terminal region of the C protein in IFN signaling. Furthermore, our results indicate that the charged amino acid residues within the N-terminal region of the C protein regulate the antagonistic effect of the C protein on IFN signaling.
Insights
Human parainfluenza virus type 3 (HPIV3) C protein hinders innate immunity. Truncating its N-terminus partially restores interferon signaling, highlighting the N-terminal region
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Human parainfluenza virus type 3 (HPIV3) is a paramyxovirus that employs its accessory C protein to counteract host innate immunity.
- The HPIV3 C protein inhibits interferon (IFN)-mediated signaling pathways, including the phosphorylation of Signal Transducer and Activator of Transcription (Stat) 1 and gamma Interferon Activation Factor (GAF) complex formation.
- This inhibition abrogates the antiviral activity of IFNs against viral replication, such as vesicular stomatitis virus (VSV).
Purpose of the Study:
- To investigate the role of the N-terminal region of the HPIV3 C protein in antagonizing interferon signaling.
- To identify specific domains or residues within the C protein critical for its interaction with the host innate immune response.
Main Methods:
- Site-directed mutagenesis was employed to create N-terminal truncated mutants of the HPIV3 C protein (CNdelta25 and CNdelta50).
- Interferon-induced responses, including Stat1 phosphorylation and GAF complex formation, were analyzed in the presence of wild-type and mutant C proteins.
- The impact of charged amino acid residues within the N-terminal region on C protein function was assessed.
Main Results:
- N-terminal truncation of the HPIV3 C protein (CNdelta25 and CNdelta50) resulted in a substantial recovery (approximately 50%) of IFN-induced responses.
- These findings indicate that the N-terminal region of the C protein plays a critical role in its antagonistic activity against IFN signaling.
- Charged amino acid residues within the N-terminal region were identified as key regulators of the C protein's inhibitory effect on IFN signaling.
Conclusions:
- The N-terminal region of the HPIV3 C protein is essential for its function as an antagonist of the host interferon-mediated innate immune response.
- Specific charged amino acid residues within this N-terminal region are crucial for modulating the C protein's ability to suppress IFN signaling.
- Understanding these interactions provides insights into HPIV3 pathogenesis and potential therapeutic targets.
Related Concept Videos
Leaky Scanning
Phosphoinositides and PIPs
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
The JAK-STAT Signaling Pathway
IP3/DAG Signaling Pathway
Influenza
Inhibitors of Viral Protein Synthesis

